Tfg Asset Management Gp LTD Autolus Therapeutics PLC Transaction History
Tfg Asset Management Gp LTD
- $453 Million
- Q3 2025
A detailed history of Tfg Asset Management Gp LTD transactions in Autolus Therapeutics PLC stock. As of the latest transaction made, Tfg Asset Management Gp LTD holds 9,500,000 shares of AUTL stock, worth $13.2 Million. This represents 3.44% of its overall portfolio holdings.
Number of Shares
9,500,000
Previous 9,500,000
-0.0%
Holding current value
$13.2 Million
Previous $21.7 Million
28.07%
% of portfolio
3.44%
Previous 5.47%
Shares
23 transactions
Others Institutions Holding AUTL
# of Institutions
103Shares Held
150MCall Options Held
24.6KPut Options Held
41.9K-
Mak Capital One LLC New York, NY26MShares$36.2 Million6.54% of portfolio
-
Blackstone Inc New York, NY20.5MShares$28.5 Million0.15% of portfolio
-
Syncona Portfolio LTD Guernsey, Channel Islands, X016.6MShares$23.1 Million97.83% of portfolio
-
Armistice Capital, LLC New York, NY15.6MShares$21.7 Million0.39% of portfolio
-
Schroder Investment Management Group London, X08.43MShares$11.7 Million0.01% of portfolio
About Autolus Therapeutics plc
- Ticker AUTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 90,909,800
- Market Cap $126M
- Description
- Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...